Transfer of genes into HSCs could be used to treat a variety of diseases from AIDS to cancer. Here Bordignon and Roncarolo discuss the logistics and progress of HSC gene transfer technology for the treatment of different diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kay, M. A., Glorioso, J. C. & Naldini, L. Nature Med. 7, 33–40 (2001).
Takatoku, M. et al. J. Clin. Invest. 108, 447–455 (2001).
Naldini, L. et al. Science 272, 263–267 (1996).
Miller, N. & Whelan, J. Hum. Gene Ther. 8, 803–815 (1997).
May, C. et al. Nature 406, 82–86 (2000).
Bordignon, C. et al. Science 270, 470–475 (1995).
Kohn, D. B. et al. Nature Med. 1, 1017–1023 (1995).
Kohn, D. B. et al. Nature Med. 4, 775–780 (1998).
Bordignon, C. Nature Med. 4, 19–20 (1998).
Malech, H. L. et al. Proc. Natl Acad. Sci. USA 94, 12133–12138 (1997).
Cavazzana-Calvo, M. et al. Science 288, 669–672 (2000).
Buchschacher, G. L. Jr & Wong-Staal, F. Hum. Gene Ther. 12, 1013–1019 (2001).
Rizzardi. G. P. & Pantaleo, G. in HIV Human Virus Guide (ed. Richman, D. D.) 300–310 (International Medical Press, London, 2002).
Mautino, M. R., Keiser, N. & Morgan, R. A. J. Virol. 75, 3590–3599 (2001).
Brenner, M. K. et al. Lancet 341, 85–86 (1993).
Pardoll, D. M. Clin. Immunol. 95, 44–62 (2000).
Banchereau, J. et al. Annu. Rev. Immunol. 18, 767–811 (2000).
Dallal, R. M. & Lotze, M. T. Curr. Opin. Immunol. 12, 583–588 (2000).
Falcone, M. & Sarvetnick, N. Curr. Opin. Immunol. 11, 670–676 (1999).
Tarner, I. H. & Fathman, C. G. Curr. Opin. Immunol. 13, 676–682 (2001).
Roncarolo, M. G. & Levings, M. K. Curr. Opin. Immunol 12, 676–683 (2000).
Zhang, J., Vandevyver, C., Stinissen, P. & Raus, J. J. Immunol. 155, 5868–5877 (1995).
Vandenbark, A. A. et al. Nature Med. 2, 1109–1115 (1996).
Yao, Q. et al. J. Gene Med. 2, 210–219 (2000).
Hoekzema, R., Hannema, A. J., Swaak, T. J., Paardekooper, J. & Hack, C. E. J. Immunol. 135, 265–271 (1985).
Groux, H. et al. Nature 389, 737–742 (1997).
Tomita, Y., Khan, A. & Sykes, M. J. Immunol. 153, 1087–1098 (1994).
Lee, H. C., Kim, S. J., Kim, K. S., Shin, H. C. & Yoon, J. W. Nature 408, 483–488 (2000).
Lumelsky, N. et al. Science 292, 1389–1394 (2001).
Ardouin, L. et al. J. Exp. Med. 187, 105–116 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bordignon, C., Roncarolo, M. Therapeutic applications for hematopoietic stem cell gene transfer. Nat Immunol 3, 318–321 (2002). https://doi.org/10.1038/ni0402-318
Issue Date:
DOI: https://doi.org/10.1038/ni0402-318
This article is cited by
-
Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID
Immunologic Research (2009)
-
Toward ‘SMART’ stem cells
Gene Therapy (2008)
-
Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells
Journal of Cancer Research and Clinical Oncology (2007)
-
Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element
Gene Therapy (2006)
-
Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus
Gene Therapy (2006)